26,525 research outputs found
Zhengzhou (China), aerial view of engineers' camp from the upstream at Huayuankou
No full textAirplane view of engineers' camp at Huayuankou just upstream from closure. Aug 20, 1947.Image is part of research conducted by O. J. Todd for the article: The Yellow River Reharnessed
Author(s): O. J. Todd
Source: Geographical Review, Vol. 39, No. 1 (Jan., 1949), pp. 38-56
Published by: American Geographical Society
Stable URL: http://www.jstor.org/stable/211156http://www.jstor.org/stable/211156Grayscal
Zhengzhou (China), aerial view of closure structure at Huayuankou
No full textAirplane view of closure structure at Huayuankou, 1500 feet west of east end. August 20, 1947.Image is part of research conducted by O. J. Todd for the article: The Yellow River Reharnessed
Author(s): O. J. Todd
Source: Geographical Review, Vol. 39, No. 1 (Jan., 1949), pp. 38-56
Published by: American Geographical Society
Stable URL: http://www.jstor.org/stable/211156http://www.jstor.org/stable/211156Grayscal
China, aerial view of Yellow River
No full textAirplane view of Yellow River delta region from 4000 feet altitude. August 21, 1947.Image is part of research conducted by O. J. Todd for the article: The Yellow River Reharnessed
Author(s): O. J. Todd
Source: Geographical Review, Vol. 39, No. 1 (Jan., 1949), pp. 38-56
Published by: American Geographical Society
Stable URL: http://www.jstor.org/stable/211156http://www.jstor.org/stable/211156Grayscal
Supplemental Material, DS2_IJT_10.1177_1091581818819791 - Investigating the Value of Urine Volume, Creatinine, and Cystatin C for Urinary Biomarkers Normalization for Drug Development Studies
No full textSupplemental Material, DS2_IJT_10.1177_1091581818819791 for Investigating the Value of Urine Volume, Creatinine, and Cystatin C for Urinary Biomarkers Normalization for Drug Development Studies by Adeyemi O. Adedeji, Tony Pourmohamad, Yafei Chen, Jennifer Burkey, Catherine J. Betts, Susan J. Bickerton, Manisha Sonee, and James E. McDuffie in International Journal of Toxicology</p
Supplemental Material, DS1_IJT_10.1177_1091581818819791 - Investigating the Value of Urine Volume, Creatinine, and Cystatin C for Urinary Biomarkers Normalization for Drug Development Studies
No full textSupplemental Material, DS1_IJT_10.1177_1091581818819791 for Investigating the Value of Urine Volume, Creatinine, and Cystatin C for Urinary Biomarkers Normalization for Drug Development Studies by Adeyemi O. Adedeji, Tony Pourmohamad, Yafei Chen, Jennifer Burkey, Catherine J. Betts, Susan J. Bickerton, Manisha Sonee, and James E. McDuffie in International Journal of Toxicology</p
Evidence for the decay B0→J/ψω and measurement of the relative branching fractions of meson decays to J/ψη and J/ψη′
No full textFirst evidence of the B 0 → J / ψ ω decay is found and the B s 0 → J / ψ η and B s 0 → J / ψ η ′ decays are studied using a dataset corresponding to an integrated luminosity of 1.0 fb -1 collected by the LHCb experiment in proton-proton collisions at a centre-of-mass energy of sqrt(s) = 7 TeV. The branching fractions of these decays are measured relative to that of the B 0 → J / ψ ρ 0 decay:frac(B (B 0 → J / ψ ω), B (B 0 → J / ψ ρ 0)) = 0.89 ± 0.19 (stat) - 0.13 + 0.07 (syst),frac(B (B s 0 → J / ψ η), B (B 0 → J / ψ ρ 0)) = 14.0 ± 1.2 (stat) - 1.5 + 1.1 (syst) - 1.0 + 1.1 (frac(f d, f s)),frac(B (B s 0 → J / ψ η ′), B (B 0 → J / ψ ρ 0)) = 12.7 ± 1.1 (stat) - 1.3 + 0.5 (syst) - 0.9 + 1.0 (frac(f d, f s)), where the last uncertainty is due to the knowledge of f d / f s, the ratio of b-quark hadronization factors that accounts for the different production rate of B 0 and B s 0 mesons. The ratio of the branching fractions of B s 0 → J / ψ η ′ and B s 0 → J / ψ η decays is measured to befrac(B (B s 0 → J / ψ η ′), B (B s 0 → J / ψ η)) = 0.90 ± 0.09 (stat) - 0.02 + 0.06 (syst)
Methodology matters ⋯ but so does interpretation!
No full text[No abstract available]Abbas O, 2009, BRIT J DERMATOL, V161, P228, DOI 10.1111-j.1365-2133.2009.09250.x; Abbas O, 2011, J EUR ACAD DERMATOL, V25, P311, DOI 10.1111-j.1468-3083.2010.03791.x; Amoh Y, 2005, P NATL ACAD SCI USA, V102, P17734, DOI 10.1073-pnas.0508440102; Amoh Y, 2005, P NATL ACAD SCI USA, V102, P5530, DOI 10.1073-pnas.0501263102; Amoh Y, 2004, P NATL ACAD SCI USA, V101, P13291, DOI 10.1073-pnas.0405250101; Amoh Y, 2011, EUR J DERMATOL, V21, P209, DOI 10.1684-ejd.2011.1306; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158-1078-0432.CCR-07-4404; FIALKOW PJ, 1967, P NATL ACAD SCI USA, V58, P1468, DOI 10.1073-pnas.58.4.1468; HAMBURGER AW, 1977, SCIENCE, V197, P461, DOI 10.1126-science.560061; Hoang MP, 2009, BRIT J DERMATOL, V160, P609, DOI 10.1111-j.1365-2133.2008.09015.x; Kanoh M, 2008, EUR J DERMATOL, V18, P518, DOI 10.1684-ejd.2008.0485; Li LN, 2003, P NATL ACAD SCI USA, V100, P9958, DOI 10.1073-pnas.1733025100; Lim YC, 2011, ORAL ONCOL, V47, P83, DOI 10.1016-j.oraloncology.2010.11.011; Mahalingam M, 2010, AM J DERMATOPATH, V32, P774, DOI 10.1097-DAD.0b013e3181dafd8c; Mignone JL, 2007, CELL CYCLE, V6, P2161; Misago N, 2009, BRIT J DERMATOL, V160, P1128, DOI 10.1111-j.1365-2133.2009.09075.x; Reya T, 2001, NATURE, V414, P105, DOI 10.1038-35102167; Ryuge S, 2011, CHEST, V139, P862, DOI 10.1378-chest.10-1121; Sakuma H, 2009, J DERMATOL, V36, P453, DOI 10.1111-j.1346-8138.2009.00675.x; Sellheyer K, 2011, J CUTAN PATHOL, V38, P460, DOI 10.1111-j.1600-0560.2010.01671.x; Sellheyer K, 2010, J AM ACAD DERMATOL, V63, P93, DOI 10.1016-j.jaad.2009.07.013; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038-sj.onc.1207946; Uchugonova A, 2011, J CELL BIOCHEM, V112, P2046, DOI 10.1002-jcb.23122; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016-j.tcb.2005.07.004; Wang Y, 2006, CELL BIOL INT, V30, P144, DOI 10.1016-j.cellbi.2005.09.0050
Epidermotropic lesions: A review
No full textEpidermotropism describes the spread of cells of lymphocytic, epithelial melanocytic, neuroendocrine, histiocytic or muscular origin into the epidermis from an underlying dermal or subcutaneous pathology, that may be primary cutaneous or metastatic. In this review, we aim to discuss the differential diagnosis of epidermotropic lesions and highlight the histological and immunohistochemical characteristics that can help in their differentiation. Abbas O, Bhawan J. Epidermotropic lesions: a review. © 2009 John Wiley and Sons A-S.AGUILAR A, 1991, AM J DERMATOPATH, V13, P452, DOI 10.1097-00000372-199110000-00004; Al-Hoqail IA, 2002, J CUTAN PATHOL, V29, P291, DOI 10.1034-j.1600-0560.2002.290506.x; Allan SJR, 1998, BRIT J DERMATOL, V138, P689; ALVARES C, 2000, MODERN PATHOL, V13, pA60; ANSAI S, 1993, HISTOPATHOLOGY, V22, P127, DOI 10.1111-j.1365-2559.1993.tb00090.x; Arai E, 2007, ARCH DERMATOL, V143, P53, DOI 10.1001-archderm.143.1.53; Aslan F, 2006, J CUTAN PATHOL, V33, P531, DOI 10.1111-j.1600-0560.2006.00466.x; BAPTISTA AP, 1993, ANN DERMATOL VENER, V120, P107; BENGOECHEABEEBY MP, 1993, CANCER, V72, P1909, DOI 10.1002-1097-0142(19930915)72:61909::AID-CNCR28207206193.0.CO;2-S; Benouni S, 2007, ARCH DERMATOL, V143, P358, DOI 10.1001-archderm.143.3.358; Berti E, 1999, AM J PATHOL, V155, P483, DOI 10.1016-S0002-9440(10)65144-9; BISHOP PW, 1993, HISTOPATHOLOGY, V23, P159, DOI 10.1111-j.1365-2559.1993.tb00474.x; Boardman CH, 2001, GYNECOL ONCOL, V82, P200, DOI 10.1006-gyno.2001.6222; BOYD AS, 1994, J AM ACAD DERMATOL, V31, P740; Brainard JA, 2000, AM J SURG PATHOL, V24, P543, DOI 10.1097-00000478-200004000-00008; Brasanac D, 2003, J CUTAN PATHOL, V30, P641, DOI 10.1034-j.1600-0560.2003.00130.x; Brown HA, 2000, AM J DERMATOPATH, V22, P65, DOI 10.1097-00000372-200002000-00013; Brown HM, 2002, HUM PATHOL, V33, P545, DOI 10.1053-hupa.2002.124787; Burg G, 2005, J CUTAN PATHOL, V32, P647, DOI 10.1111-j.0303-6987.2005.00495.x; BURNS MK, 1995, ARCH DERMATOL, V131, P325, DOI 10.1001-archderm.131.3.325; BUSAM KJ, 1995, AM J SURG PATHOL, V19, P1061, DOI 10.1097-00000478-199509000-00010; Callahan EF, 2004, DERMATOL SURG, V30, P1164, DOI 10.1111-j.1524-4725.2004.30348.x; CARTWRIGHT L E, 1987, Journal of the American Academy of Dermatology, V17, P887, DOI 10.1016-S0190-9622(87)70275-8; CHU A, 1982, J AM ACAD DERMATOL, V6, P350, DOI 10.1016-S0190-9622(82)70028-3; Clark SH, 2003, J CUTAN PATHOL, V30, P279, DOI 10.1046-j.0303-6987.2003.053.x; COGHILL SB, 1990, HISTOPATHOLOGY, V17, P373; de Leon ED, 2000, AM J CLIN PATHOL, V113, P572; Ferringer T, 2005, J CUTAN PATHOL, V32, P162, DOI 10.1111-j.0303-6987.2005.00270.x; Fu W, 2001, AM J CLIN ONCOL-CANC, V24, P397, DOI 10.1097-00000421-200108000-00019; Garijo MF, 2008, APMIS, V116, P139, DOI 10.1111-j.1600-0463.2008.00826.x; Garijo MF, 2001, AM J DERMATOPATH, V23, P329, DOI 10.1097-00000372-200108000-00010; Haghighi B, 2000, MODERN PATHOL, V13, P502, DOI 10.1038-modpathol.3880088; Han MH, 2000, INT J DERMATOL, V39, P555; Hansen R C, 1991, Adv Dermatol, V6, P161; Hosler GA, 2008, J CUTAN PATHOL, V35, P889, DOI 10.1111-j.1600-0560.2008.01041.x; Iacocca MV, 1998, J AM ACAD DERMATOL, V39, P882, DOI 10.1016-S0190-9622(98)70372-X; Ihm CW, 1996, J CUTAN PATHOL, V23, P479, DOI 10.1111-j.1600-0560.1996.tb01438.x; Ishida-Yamamoto A, 2002, J CUTAN PATHOL, V29, P185, DOI 10.1034-j.1600-0560.2002.290311.x; Izban KF, 1998, MODERN PATHOL, V11, P978; Jang KA, 2000, J AM ACAD DERMATOL, V43, P511, DOI 10.1067-mjd.2000.107236; JONES RE, 1985, AM J DERMATOPATH, V7, P361, DOI 10.1097-00000372-198508000-00009; Kamarashev J, 1998, J CUTAN PATHOL, V25, P407, DOI 10.1111-j.1600-0560.1998.tb01766.x; KAMIYA T, 2006, BRIT J DERMATOL, V155, P477; Kanitakis J, 2007, J EUR ACAD DERMATOL, V21, P581, DOI 10.1111-j.1468-3083.2007.02154.x; Kapur P, 2005, MODERN PATHOL, V18, P197, DOI 10.1038-modpathol.3800281; KATO N, 1989, Journal of Dermatology (Tokyo), V16, P161; Kohler S, 1998, MODERN PATHOL, V11, P79; Kohler S, 1996, AM J DERMATOPATH, V18, P118, DOI 10.1097-00000372-199604000-00003; Kollmorgen DR, 1998, J AM COLL SURGEONS, V187, P171, DOI 10.1016-S1072-7515(98)00143-4; Kossard S, 1997, ARCH DERMATOL, V133, P1312, DOI 10.1001-archderm.133.10.1312; KUO TT, 1987, AM J SURG PATHOL, V11, P827, DOI 10.1097-00000478-198711000-00001; LANDA NG, 1991, J AM ACAD DERMATOL, V24, P27, DOI 10.1016-0190-9622(91)70004-L; Lau J, 2003, J CUTAN PATHOL, V30, P449, DOI 10.1034-j.1600-0560.2003.00096.x; Lloyd J, 2000, J CLIN PATHOL, V53, P742, DOI 10.1136-jcp.53.10.742; Marucci G, 2002, VIRCHOWS ARCH, V441, P117, DOI 10.1007-s00428-001-0581-x; MATEJKA M, 1983, WIEN KLIN WOCHENSCHR, V95, P847; MCGOVERN VJ, 1973, CANCER, V32, P1446, DOI 10.1002-1097-0142(197312)32:61446::AID-CNCR28203206233.0.CO;2-8; Mitchell S, 2006, BREAST J, V12, P233, DOI 10.1111-j.1075-122X.2006.00247.x; Ohnishi T, 2000, BRIT J DERMATOL, V142, P243, DOI 10.1046-j.1365-2133.2000.03291.x; Orella JAL, 1997, DERMATOL SURG, V23, P925; Paget J, 1874, ST BARTHOLOMEWS HOSP, V10, P87; Raju RR, 2003, INT J GYNECOL PATHOL, V22, P127, DOI 10.1097-01.PGP.0000055171.04957.F4; RAO NA, 1982, HUM PATHOL, V13, P113, DOI 10.1016-S0046-8177(82)80115-9; RAYL S, 2007, J CUTAN PATHOL, V34, P188; RAYNE SC, 1992, AM J SURG PATHOL, V16, P1085, DOI 10.1097-00000478-199211000-00007; Ribe A, 2008, J CUTAN PATHOL, V35, P24, DOI 10.1111-j.1600-0560.2008.01150.x; Robson A, 2001, AM J SURG PATHOL, V25, P710, DOI 10.1097-00000478-200106000-00002; ROSENTHAL CJ, 1982, CANCER, V49, P2305, DOI 10.1002-1097-0142(19820601)49:112305::AID-CNCR28204911183.0.CO;2-G; Saad AG, 2005, AM J DERMATOPATH, V27, P111, DOI 10.1097-01.dad.0000152022.81651.a7; Sariya D, 2007, ARCH DERMATOL, V143, P613, DOI 10.1001-archderm.143.5.613; SEGAL R, 1994, J CUTAN PATHOL, V21, P280, DOI 10.1111-j.1600-0560.1994.tb00274.x; Sellheyer K, 2008, J CUTAN PATHOL, V35, P366, DOI 10.1111-j.1600-0560.2007.00814.x; Setterfield J, 2002, AM J SURG PATHOL, V26, P938, DOI 10.1097-00000478-200207000-00014; SHAPIRO PE, 1994, AM J SURG PATHOL, V18, P645, DOI 10.1097-00000478-199407000-00001; SHIMOYAMA M, 1991, BRIT J HAEMATOL, V79, P428, DOI 10.1111-j.1365-2141.1991.tb08051.x; Smith AA, 2003, J CUTAN PATHOL, V30, P401, DOI 10.1034-j.1600-0560.2003.00080.x; SMITH KJ, 1993, AM J DERMATOPATH, V15, P528, DOI 10.1097-00000372-199312000-00002; Stockschlaeder M, 2006, EUR J HAEMATOL, V76, P363, DOI 10.1111-j.1600-0609.2006.00648.x; STRAYER DS, 1980, J CUTAN PATHOL, V7, P244, DOI 10.1111-j.1600-0560.1980.tb01223.x; TOKER C, 1970, CANCER, V25, P601, DOI 10.1002-1097-0142(197003)25:3601::AID-CNCR28202503153.0.CO;2-I; TOKER C, 1972, ARCH DERMATOL, V105, P107, DOI 10.1001-archderm.105.1.107; TOMMASO L, 2008, HUM PATHOL, V39, P1295; Toro JR, 2000, ARCH DERMATOL, V136, P1024, DOI 10.1001-archderm.136.8.1024; Trotter MJ, 1997, J CUTAN PATHOL, V24, P286, DOI 10.1111-j.1600-0560.1997.tb00793.x; TSCHEN JA, 1988, J AM ACAD DERMATOL, V19, P891, DOI 10.1016-S0190-9622(88)70250-9; Twersky JM, 2004, J AM ACAD DERMATOL, V51, P123, DOI 10.1016-j.jaad.2003.12.027; Val-Bernal JF, 2000, J CUTAN PATHOL, V27, P76; Val-Bernal JF, 2000, AM J SURG PATHOL, V24, P1518, DOI 10.1097-00000478-200011000-00007; Val-Bernal JF, 2000, J CUTAN PATHOL, V27, P387, DOI 10.1034-j.1600-0560.2000.027008387.x; WARNER TFCS, 1980, J CUTAN PATHOL, V7, P50, DOI 10.1111-j.1600-0560.1980.tb00977.x; WEIDNER N, 1985, Archives of Dermatology, V121, P1041, DOI 10.1001-archderm.121.8.1041; Williamson JD, 2000, ARCH PATHOL LAB MED, V124, P427; WILLMAN CL, 1994, NEW ENGL J MED, V331, P154, DOI 10.1056-NEJM199407213310303; WOLF R, 1985, ARCH DERMATOL, V121, P1181, DOI 10.1001-archderm.121.9.1181; Yamada Y, 2003, LEUKEMIA LYMPHOMA, V44, P611, DOI 10.1080-1042819021000055039; Yao DX, 2002, HISTOPATHOLOGY, V40, P230, DOI 10.1046-j.1365-2559.2002.01362.x; Yoshii N, 2002, PATHOL INT, V52, P390, DOI 10.1046-j.1440-1827.2002.01364.x; ZELGER B, 1992, ARCH DERMATOL, V128, P1207, DOI 10.1001-archderm.128.9.120787
Measurement of the ratio of prompt χ c to J / ψ production in pp collisions at √s = 7 TeV
No full textThe prompt production of charmonium χ c and J / ψ states is studied in proton-proton collisions at a centre-of-mass energy of √s = 7 TeV at the Large Hadron Collider. The χ c and J / ψ mesons are identified through their decays χ c → J / ψ γ and J / ψ → μ + μ - using 36 pb - 1 of data collected by the LHCb detector in 2010. The ratio of the prompt production cross-sections for χ c and J / ψ, σ (χ c → J / ψ γ) / σ (J / ψ), is determined as a function of the J / ψ transverse momentum in the range 2 < p T J / ψ < 15 GeV / c. The results are in excellent agreement with next-to-leading order non-relativistic expectations and show a significant discrepancy compared with the colour singlet model prediction at leading order, especially in the low p T J / ψ region
Measurement of the time-dependent CP asymmetry in B0 -> J/ψ KS0 decays
No full textThis Letter reports a measurement of the CP violation observables SJ/ψK0S and CJ/ψK0S in the decay channel B0→J/ψK0S performed with 1.0 fb−1 of pp collisions at s√=7 TeV collected by the LHCb experiment. The fit to the data yields SJ/ψK0S=0.73±0.07(stat)±0.04(syst) and CJ/ψK0S=0.03±0.09(stat)±0.01(syst). Both values are consistent with the current world averages and within
expectations from the Standard Model
- …
